Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
about
Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment position emission tomography in lung tumoursLipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acidsChallenges in clinical prostate cancer: role of imaging.Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironmentConsequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey.Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-cholineDual-phase PET-CT to differentiate [18F]Fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancerEarly outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abirateroneTranslational molecular imaging for cancer.Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasisThe next generation of positron emission tomography radiopharmaceuticals in oncology.Prognosis Related to Metastatic Burden Measured by ¹⁸F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer.Transbilayer phospholipids molecular imaging.Molecular imaging of prostate cancer: PET radiotracers.[18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations.Imaging in genitourinary cancer from the urologists' perspective.Choline autoradiography of human prostate cancer xenograft: effect of castrationPrediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CTQuantitative 18F-fluorocholine positron emission tomography for prostate cancer: correlation between kinetic parameters and Gleason scoring.Metabolomics: a novel approach to early and noninvasive prostate cancer detection.18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review.The fat side of prostate cancer.PET imaging in prostate cancer: focus on prostate-specific membrane antigenBiodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats.A holistic view of cancer bioenergetics: mitochondrial function and respiration play fundamental roles in the development and progression of diverse tumors.Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer.N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer.Performance characteristics and relationship of PSA value/kinetics on carbon-11 acetate PET/CT imaging in biochemical relapse of prostate cancer.Occult Prostate Cancer Detected with 18F-Fluorocholine Positron Emission Tomography/Computed Tomography.Changes in Skeletal Tumor Activity on (18)F-choline PET/CT in Patients Receiving (223)Radium Radionuclide Therapy for Metastatic Prostate Cancer.[18F]fluoromethyl-[1,2-2H4]-choline: a novel radiotracer for imaging choline metabolism in tumors by positron emission tomography.Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer.11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging.[18F]Fluorocholine PET/CT Imaging of Liver Cancer: Radiopathologic Correlation with Tissue Phospholipid Profiling.
P2860
Q24797179-34C33FBA-876B-40A9-8AC8-3CD8121CBA11Q26996516-48C4DA44-4D4D-428C-8046-783B1CF4F19EQ33945133-FE00BEC2-73E3-457B-AF88-35AC6CC8D6A1Q33955139-27EE731B-E488-4710-A3E9-67C6ADFF6E72Q34040036-AC398FFD-AA93-4F6E-A776-0085122537F5Q34203953-ECBE75CB-880D-47D7-A4C1-BA0227FE802BQ34448553-60892B16-721E-4521-9FD5-5054F23C1968Q34465066-9CA314FF-CD3D-46B7-875B-7624613A742EQ35068005-E0A0C041-D8C3-48E2-AF3C-6ED7F0AB85DDQ35173093-2C837609-2C0E-4639-B796-051ABC0A012BQ35183953-378AF315-53A8-463A-B747-C63C25DB46A2Q35525690-07521635-2FD8-4F5C-A292-F0B1411858AAQ35582133-3E1CCD1E-5D33-44F8-9EA2-939601BBAE84Q35650805-74AD8562-C060-4D34-AA2B-0978540589BAQ36129937-7985A2ED-F488-4D42-BBB9-24B4242B7143Q36236041-8A18C8AF-923B-4036-9FAE-45ED6D027382Q36834536-2D3DC2B7-0843-4AD3-8531-C2D5C9B1A28AQ37052606-324B5BAE-1DA9-49B4-8BCD-655FBE57A0F4Q37496697-461683BC-386A-46F2-B70D-0C3A739077FEQ37714485-A6DEC2B6-7165-4396-9A2C-5A35F1BCB2B5Q37850315-E0458B6B-D7A1-46B1-A749-B452DD80222BQ37918311-F9457E0D-4261-48AD-95B8-E89248ECA094Q37973351-F36783E0-E97B-4252-AA15-7101512670D4Q38096735-8D2DA3CA-8E37-4B37-AC16-A9EC0AF8D6B5Q38099369-7230819E-1675-4DDB-99FD-5DF181700406Q38532173-799D29F1-E0AA-43BD-BA41-C594F4A29CB3Q38712122-A87E6AA4-6F25-426C-A3B0-E7E5A1AC8FDDQ39571686-DE24E30D-6AC1-4318-8358-36097125E404Q41447911-F132A594-1F38-4C12-9A6E-402742D5C680Q41913170-E5535781-8CBD-42F4-B45D-956B1BDAA8BFQ42230054-1B5387A5-CB6E-4F47-A2FE-4D89AF6C1A97Q42286329-2F2C3F7C-A0F6-474C-ABB5-BB5676BED047Q42530668-AA80FC7F-66DA-4931-B76A-BB5CCD60268CQ42575907-A14FE191-A20C-44DF-8AD5-1439AFEE1606Q44453209-2F0D1F0A-DA21-4837-B9A9-EB4C030F682EQ46423707-4B80F4F8-4405-44B8-B621-EF2569991400Q46469807-91E052E8-FC98-4AC2-ADC4-EC4CE6E7E714
P2860
Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Comparison of [18 F]fluorochol ...... n independent prostate cancer.
@en
Comparison of [18 F]fluorochol ...... n independent prostate cancer.
@nl
type
label
Comparison of [18 F]fluorochol ...... n independent prostate cancer.
@en
Comparison of [18 F]fluorochol ...... n independent prostate cancer.
@nl
prefLabel
Comparison of [18 F]fluorochol ...... n independent prostate cancer.
@en
Comparison of [18 F]fluorochol ...... n independent prostate cancer.
@nl
P2093
P1476
Comparison of [18 F]fluorochol ...... n independent prostate cancer.
@en
P2093
Cary N Robertson
David T Price
R Edward Coleman
Ray P Liao
Thomas J Polascik
Timothy R DeGrado
P304
P356
10.1097/00005392-200207000-00090
P407
P577
2002-07-01T00:00:00Z